EU MDR Readiness Reviews — Structured, Independent, Fixed-Scope
B Plus Solutions delivers independent regulatory document reviews for EU MDR compliance.
Structured feedback. Clear risk flags. Submission-ready insight.
Our Services
Regulatory and Strategic Support
EU MDR regulatory strategy, gap assessments, mock audits, and technical documentation review to support manufacturers in preparing compliant and submission-ready documentation.
Clinical and Post-Market Documentation
Clinical Evaluation (CEP, CER, SSCP), PMS and PMCF documentation, literature reviews, and post-market regulatory documentation aligned with EU MDR requirements.
About B+ Solutions
B+ Solutions provides independent regulatory and clinical documentation support for medical device manufacturers navigating EU MDR requirements. With experience on both the manufacturer side and the notified body side, B+ Solutions understands how technical documentation is developed, reviewed, and assessed during conformity assessment. This perspective allows us to deliver structured, practical feedback that strengthens regulatory submissions and helps teams move forward with confidence.
● LIVE
Industry & Compliance Updates
"medical device" - Google News Google News
- Abbott Laboratories stock (US0028241000): Why Google Discover changes matter more now - AD HOC NEWSon 20 April 2026 at 13:45
Abbott Laboratories stock (US0028241000): Why Google Discover changes matter more now AD HOC NEWS
- Infant Phototherapy Lamps Market Set for Strong Growth Amid - openPR.comon 20 April 2026 at 13:07
Infant Phototherapy Lamps Market Set for Strong Growth Amid openPR.com
- Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease - Investing News Networkon 20 April 2026 at 13:06
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease Investing News Network
- Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer - Investing News Networkon 20 April 2026 at 13:06
Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer Investing News Network
- ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network - The Manila Timeson 20 April 2026 at 12:42
ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network The Manila Times